Research and Development Expenses
First written in FY2017-Q3. 24 of 28 entries say "Restated". Latest entry: FY2026.
- FY2026Higher research and development expensesAnnual report
「Group-wide research and development expenses for the consolidated fiscal year were ¥474 million.」
Full-year research and development expenses were ¥474 million, up from ¥391 million in the previous fiscal year. Development of new and seasonal menu offerings for dormitories and hotels was continuing. - FY2024Higher research and development expensesAnnual report
「Group-wide research and development expenses for the consolidated fiscal year were ¥391 million.」
Full-year research and development expenses were ¥391 million, up from ¥364 million in the previous fiscal year. - FY2024-Q3RestatedAnnual report
「Group-wide research and development expenses for the first nine months of the consolidated fiscal year were ¥288 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the consolidated fiscal year.」
Disclosed research and development expenses of ¥288 million for the first nine months and stated that there were no material changes in research and development activities. - FY2024-Q1RestatedAnnual report
「Group-wide research and development expenses for the first quarter of the consolidated fiscal year were ¥90 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the consolidated fiscal year.」
Disclosed research and development expenses of ¥90 million for the first quarter and stated that there were no material changes in research and development activities. - FY2023Higher research and development expensesAnnual report
「Group-wide research and development expenses for the consolidated fiscal year were ¥364 million.」
Full-year research and development expenses were ¥364 million, up from ¥339 million in the previous fiscal year. Research and development focused on developing new and seasonal menu offerings for dormitories and hotels. - FY2023-Q3RestatedAnnual report
「Group-wide research and development expenses for the first nine months of the consolidated fiscal year were ¥275 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the consolidated fiscal year.」
Disclosed research and development expenses of ¥275 million for the first nine months and stated that there were no material changes in research and development activities. - FY2023-Q2RestatedAnnual report
「Group-wide research and development expenses for the first half of the consolidated fiscal year were ¥178 million. There were no material changes in the status of the Group's research and development activities during the first half of the consolidated fiscal year.」
Disclosed research and development expenses of ¥178 million for the first half and stated that there were no material changes in research and development activities. - FY2023-Q1RestatedAnnual report
「Group-wide research and development expenses for the first quarter of the consolidated fiscal year were ¥89 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the consolidated fiscal year.」
Disclosed research and development expenses of ¥89 million for the first quarter and stated that there were no material changes in research and development activities. - FY2022RestatedAnnual report
「Group-wide research and development expenses for the consolidated fiscal year were ¥339 million.」
Disclosed full-year research and development expenses of ¥339 million. - FY2022-Q3RestatedAnnual report
「Group-wide research and development expenses for the first nine months of the consolidated fiscal year were ¥250 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the consolidated fiscal year.」
Disclosed research and development expenses of ¥250 million for the first nine months and stated that there were no material changes in the status of research and development activities. - FY2022-Q2RestatedAnnual report
「Group-wide research and development expenses for the first half of the consolidated fiscal year were ¥165 million.」
Disclosed research and development expenses of ¥165 million for the first half and stated that there were no material changes in the status of research and development activities. - FY2022-Q1RestatedAnnual report
「Group-wide research and development expenses for the first quarter of the consolidated fiscal year were ¥82 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the consolidated fiscal year.」
Stated that research and development expenses were ¥82 million and that there were no material changes in research and development activities. - FY2021RestatedAnnual report
「Group-wide research and development expenses for the consolidated fiscal year were ¥300 million.」
Disclosed full-year research and development expenses of ¥300 million and stated that development of new and seasonal menu offerings for dormitories and hotels was continuing. - FY2021-Q3RestatedAnnual report
「Group-wide research and development expenses for the first nine months of the consolidated fiscal year were ¥226 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the consolidated fiscal year.」
Stated that research and development expenses for the first nine months were ¥226 million and that there were no material changes in the status of research and development activities. - FY2021-Q2RestatedAnnual report
「Group-wide research and development expenses for the first half of the consolidated fiscal year were ¥155 million. There were no material changes in the status of the Group's research and development activities during the first half of the consolidated fiscal year.」
Disclosed research and development expenses of ¥155 million for the first half and stated that there were no material changes in research and development activities. - FY2021-Q1RestatedAnnual report
「Group-wide research and development expenses for the first quarter of the consolidated fiscal year were ¥82 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the consolidated fiscal year.」
Stated that first-quarter research and development expenses were ¥82 million and that there were no material changes in research and development activities. - FY2020RestatedAnnual report
「Group-wide research and development expenses for the consolidated fiscal year were ¥270 million.」
Disclosed full-year research and development expenses of ¥270 million, down from ¥285 million in the previous fiscal year. - FY2020-Q3RestatedAnnual report
「Group-wide research and development expenses for the first nine months of the consolidated fiscal year were ¥207 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the consolidated fiscal year.」
Disclosed research and development expenses of ¥207 million for the first nine months and stated that there were no material changes in research and development activities. - FY2020-Q2RestatedAnnual report
「Group-wide research and development expenses for the first half of the consolidated fiscal year were ¥145 million. There were no material changes in the status of the Group's research and development activities during the first half of the consolidated fiscal year.」
Disclosed research and development expenses of ¥145 million for the first half and stated that there were no material changes in research and development activities. - FY2020-Q1RestatedAnnual report
「Group-wide research and development expenses for the first quarter of the consolidated fiscal year were ¥78 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the consolidated fiscal year.」
Disclosed first-quarter research and development expenses of ¥78 million and stated that there were no material changes in research and development activities. - FY2019RestatedAnnual report
「Group-wide research and development expenses for the consolidated fiscal year were ¥285 million.」
Disclosed full-year research and development expenses of ¥285 million, up from ¥268 million in the previous fiscal year. - FY2019-Q2RestatedAnnual report
「The amount spent on research and development activities by the group as a whole during the cumulative second-quarter period was ¥148 million.」
Disclosed research and development expenses of ¥148 million for the first half of the consolidated fiscal year and stated that there were no material changes in research and development activities. - FY2019-Q1RestatedAnnual report
「Group-wide research and development expenses for the first quarter of the consolidated fiscal year were ¥72 million.」
Disclosed research and development expenses of ¥72 million for the first quarter of the consolidated fiscal year. - FY2018RestatedAnnual report
「Group-wide research and development expenses for the consolidated fiscal year were ¥268 million.」
Disclosed full-year research and development expenses of ¥268 million. - FY2018-Q3RestatedAnnual report
「The amount spent on research and development activities by the group as a whole during the consolidated cumulative third-quarter period was ¥191 million.」
The company disclosed group-wide research and development expenses of ¥191 million for the consolidated cumulative third-quarter period. - FY2018-Q2RestatedAnnual report
「The amount spent on research and development activities by the group as a whole during the consolidated cumulative second-quarter period was ¥129 million.」
The company disclosed group-wide research and development expenses of ¥129 million for the consolidated cumulative second-quarter period. - FY2018-Q1RestatedAnnual report
「The amount spent on research and development activities by the group as a whole during the consolidated cumulative first-quarter period was ¥66 million.」
The company disclosed research and development expenses of ¥66 million for the consolidated cumulative first-quarter period. - FY2017-Q3First statedAnnual report
「The amount spent on research and development activities by the group as a whole during the consolidated cumulative third-quarter period was ¥162 million.」
The company disclosed group-wide research and development expenses of ¥162 million for the consolidated cumulative third-quarter period.